Experts Agree that Action is Needed to Address Cancer Care in Poorer Countries (09-8-2010)

The Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries (GTF.CCC), made up of global health and oncology experts, works toward developing and implementing strategies to provide poorer countries with cancer prevention... Continue Reading

Preventive Surgery Reduces Cancer Risk in Women with BRCA1 or BRCA2 Mutations (09-8-2010)

Among women with a BRCA1 or BRCA2 gene mutation, prophylactic mastectomy (preventive removal of the breasts) reduces the risk of getting breast cancer. Prophylactic salpingo-oophorectomy (preventive removal of the fallopian tubes and ovaries) reduces... Continue Reading

Brothers of Prostate Cancer Patients Undergo More Diagnostic Testing (09-7-2010)

Some of the elevated risk of prostate cancer among those with a family history of the disease may be due to increased prostate cancer testing and detection in this population. These findings were recently published in the Journal of the National Cancer... Continue Reading

Addition of Sutent to Tarceva Does Not Improve Overall Survival with Advanced Non-Small Cell Lung Cancer (09-7-2010)

Among patients with previously treated non-small cell lung cancer, the combination of Sutent® (sunitinib) and Tarceva® (erlotinib) delays cancer progression but does not improve overall survival compared with Tarceva alone. The results of this Phase... Continue Reading

Alcohol Linked with Lobular Breast Cancer (09-3-2010)

Although alcohol is a well-established risk factor for breast cancer, it may be more strongly linked with lobular breast cancer than with ductal breast cancer. These results were published in the Journal of the National Cancer Institute. Research suggests... Continue Reading

Rectal Cancer Increasing in People Under 40 (09-2-2010)

Although still relatively uncommon in young people, the incidence of rectal cancer appears to be increasing in this population. These results were published in the journal Cancer. Colorectal cancer is the second leading cause of cancer death in the United... Continue Reading

Early Palliative Care Linked with Longer Lung Cancer Survival (09-1-2010)

Palliative care is care that is focused on symptom management, psychosocial issues, decision-making, and quality of life. Among patients with newly diagnosed, metastatic, non-small cell lung cancer, the addition of early palliative care to standard cancer... Continue Reading

Istodax Active against Refractory Cutaneous T-cell Lymphoma (08-31-2010)

Final results from a Phase II clinical trial provide additional evidence that Istodax® (romidepsin) is active against refractory cutaneous T-cell lymphoma. These results were published in the Journal of Clinical Oncology. Cutaneous T-cell lymphoma (CTCL)... Continue Reading

Estrogen Alone Does Not Increase Lung Cancer Incidence or Mortality in Postmenopausal Women (08-30-2010)

Among postmenopausal women, hormone therapy with estrogen alone does not appear to increase the risk of getting or dying from lung cancer. These results were published in the Journal of the National Cancer Institute. As women reach menopause and beyond,... Continue Reading

Reduced-intensity Treatment May be Effective for Early Hodgkin’s Lymphoma (08-27-2010)

Among patients with early-stage Hodgkin’s lymphoma and a favorable prognosis, it may be possible to reduce the number of chemotherapy cycles and the dose of radiation therapy without adversely affecting outcome. The results of this study were published... Continue Reading

Death from Other Causes Among Men with Early-stage Prostate Cancer (08-26-2010)

Among men with early-stage prostate cancer, assessment of other health problems may help guide prostate cancer treatment decisions; men who are likely to die of causes other than prostate cancer may not benefit from aggressive prostate cancer treatment.... Continue Reading

Vectibix Does Not Improve Head and Neck Cancer Survival (08-26-2010)

Among patients with recurrent and/or metastatic, squamous cell head and neck cancer, the addition of the targeted therapy Vectibix® (panitumumab) to chemotherapy does not result in significantly better survival than chemotherapy alone. The results of... Continue Reading